Skip to main content

D. E. Shaw & Co., Inc.

Position in PACB — Pacific Biosciences Of California, Inc.

CIK 1009207 New York, NY

Position in PACB

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$7,069,684
+$2,268,123 QoQ
Shares Held
4,208,146
+15.7% QoQ
Ownership
1.35%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#11
of 222 holders
Holding Since
Mar 2020
21 quarters on record
Voting authority Sole 99% Shared 0% None 1%

Common Shares in PACB Over Time

Shares Held

Position Value (USD)

Derivatives in PACB

reported options exposure · as of Mar 31, 2024
CallValue
$0
CallShares
0
PutValue
$51,000
PutShares
13,600

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Medical Devices

Healthcare · as of Jun 30, 2026

D. E. Shaw & Co., Inc. holds $2,449,763,142 across 60 Medical Devices names. PACB ranks #25 (0.3% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in PACB

Export CSV
24 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $7,069,684 4,208,146
2026-03-31 $4,801,561 3,637,547
2025-12-31 $8,299,569 4,438,273
2025-06-30 $39,770 32,073
2024-06-30 $2,254,333 1,645,499
2024-03-31 $3,034,725 809,260
2024-03-31 $51,000 13,600
2023-12-31 $106,487 10,855
2023-09-30 $360,193 43,137
2023-06-30 $9,597,705 721,632
2023-03-31 $7,124,605 615,251
2022-12-31 $2,115,944 258,673
2022-09-30 $1,021,752 175,861
2022-06-30 $10,600,428 2,398,287
2022-03-31 $6,574,995 722,527
2021-12-31 $24,229,018 1,184,214
2021-09-30 $39,457,682 1,544,332
2021-06-30 $1,818,440 52,000
2021-06-30 $38,971,232 1,114,419
2021-06-30 $227,305 6,500
2021-03-31 $7,146,493 214,545
2020-09-30 $1,352,180 136,999
2020-06-30 $1,499,618 434,672
2020-03-31 $652,018 213,078